A Study On The Effect Of Vitano® On Physiological And Psychological Responses To Psychological Stress

Exclusion Criteria

• •The subject is pregnant or breast feeding.
• •The subject consumes more than 5 caffeine-containing beverages per day.
• •The subject is colour blind.
• •Clinically significant hepatic or renal abnormality as determined by laboratory tests.
• •BMI above 33.
• •History of alcohol, narcotic, benzodiazepine, or other substance abuse or dependence within the 12 months preceding Visit 1.
• •Positive alcohol breath test at any visit. A repeat test will not be allowed. \[NOTE: subjects must be told to avoid consumption of alcoholic beverages for at least 24 hours prior to attending the Centre\].
• •Use of any other medication which may interfere with study outcome and/or interfere with IMP within the 2 weeks or 5 half lives preceding the first treatment phase, with the exception of contraceptive pill, non-steroidal analgesics, and paracetamol. \[NOTE: Concomitant medications which do not influence study outcome and/or do not interfere with IMP may be allowed at the discretion of the Investigator\].
• •Current participation in another clinical trial with an investigational or non-investigational drug or device, or participation in another clinical trial within the 3 months preceding Visit 1 (screening visit).
• •Any condition that, in the Investigator's opinion, compromises the subject's ability to meet protocol requirements or to complete the study.
• •Moderate or severe anxiety\* \*If participants are found to have moderate or severe anxiety during the screening process then they will be referred to the University Counselling service.